omeprazole and tegaserod

omeprazole has been researched along with tegaserod in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Featherstone, EA1
Chen, Y; Earnest, DL; Rojavin, M; Tougas, G; Vanderkoy, C1
Cowan, A; Earnest, DL; Ligozio, G; Rojavin, MA1

Reviews

2 review(s) available for omeprazole and tegaserod

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Severe GERD: effective treatment prevents potentially serious complications.
    JAAPA : official journal of the American Academy of Physician Assistants, 2005, Volume: 18, Issue:4

    Topics: Diagnosis, Differential; Digestive System Surgical Procedures; Education, Medical, Continuing; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Indoles; Metoclopramide; Omeprazole; Proton Pump Inhibitors

2005

Trials

1 trial(s) available for omeprazole and tegaserod

ArticleYear
Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
    Alimentary pharmacology & therapeutics, 2005, Jul-01, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Anti-Ulcer Agents; Double-Blind Method; Drug Combinations; Drug Interactions; Gastric Emptying; Gastrointestinal Agents; Humans; Indoles; Male; Omeprazole

2005

Other Studies

5 other study(ies) available for omeprazole and tegaserod

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod.
    European journal of pharmacology, 2005, Jul-04, Volume: 517, Issue:1-2

    Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Gastrointestinal Agents; Gastrointestinal Transit; Indoles; Intestine, Small; Male; Mice; Omeprazole

2005
chemdatabank.com